Protection against lethal polymicrobial sepsis by CNI-1493,an inhibitor of pro-inflammatory cytokine synthesis

Abstract

Polymicrobial sepsis caused by cecal ligation and puncture (CLP) in mice produces the inflammatory and pathological sequelae of lung neutrophil infiltration, adult respiratory distress syndrome (ARDS) and death. These sequelae are dependent upon the synergistic interaction between several inflammatory mediators, including tumor necrosis factor (TNF), interleukin 1 (IL-1 ), and nitric oxide (NO). The overlapping spectrum of multiple mediator toxicity has hampered efforts to develop therapies for sepsis based on selective inhibition of a single mediator. Therefore, we tested the hypothesis that inhibition of multiple pro-inflammatory mediators would abrogate lethality. Our results show that administration of a tetravalent guanylhydrazone compound (CNI-1493) protected mice against 10 day mortality in CLP. Evidence of suppression of the cytokine cascade was given by decreased serum levels of TNF and IL-6 in CNI-1493 treated animals (TNF reduced 60% as compared to controls; IL-6 reduced 90% compared to controls; P < 0.05), and decreased levels of the acute-phase protein serum amyloid A response measured 24 h after CLP. Serum nitrites/nitrates, which give an index of NO production, were also significantly reduced (50%). Protection against CLP induced lung damage was observed as attenuation of edema and alveolar neutrophil infiltration, suppression of pulmonary TNF levels, and reduction of TUNEL-positive staining in lung. We conclude that CNI-1493 effectively inhibits the synthesis of multiple pro-inflammatory mediators and protects against death during polymicrobial sepsis.

Get full access to this article

View all access options for this article.

References

Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-1477.

Windsor A.C.J. , Walsh C.J. , Mullen P.G. , et al. Tumor necrosis factor-α blockade prevents neutrophil CD 18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation . J Clin Invest 1993; 91: 1459-1468.

Tracey K.J. Tumor necrosis factor alpha. In: Thomson A.W Ed The Cytokine Handbook, 2nd edn. New York: Academic Press , 1994; 289-304.

Saez-Llorens X. , McCracken G.H. Sepsis syndrome and septic shock in pediatrics: current concept of terminology, pathophysiology, and management. J Pediatr 1993; 123: 497-508.

Abraham E. , Wunderink R. , Silverman H. , et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis syndrome. JAMA 1995; 273: 934-941.

Fisher C.J. et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996; 334: 1697-1702.

Fisher C.J. et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994 ; 271: 1836-1843.

Zeni F. , Pain P. , Vindimian M. , et al. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med 1996; 24: 207-214.

Waage A. , Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J Exp Med 1988; 167: 1987-1992.

10.

Vogel S.N. , Kaufman E.N. , Tate M.D. , Neta R. Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 1988; 56: 2650-2657

11.

Bianchi M. , Ulrich P. , Bloom O. , et al. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality . Mol Med 1995; 1: 254-266.

12.

Bianchi M. , Bloom O. , Raabe T. , et al. Suppression of pro-inflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 1996 ; 183: 927-936.

13.

Cohen P.S. , Nakshatri H. , Dennis J. , et al. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci USA 1996; 93: 3967-3971.

14.

Cohen P.S. , Schmidtmayerova H. , Dennis J. et al. The critical role of p38 MAP kinase in T cell HIV-1 replication . Mol Med 1997; 3: 339-346.

15.

Baker C.C. , Chaudri I.H. , Gaines H.O. , Baue A.E. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94: 331-335.

16.

Villa P. , Sartor G. , Angelini M. , et al. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immun 1995; 2: 549-553.

17.

Goya T. , Abe M. , Shimura H. , Torisu M. Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol 1992; 52: 236-243.

18.

Echtenacher B. , Falk W. , Mannel D.N. , Krammer P.H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145: 3762-3766.

19.

Goldblum S.E. , Wu K.M. , Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 1985 ; 59: 1978-1985.

20.

Gavrieli Y. , Sherman Y. , Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.

21.

Uchiba M. , Okajima K. , Murakami K. , Okabe H. , Takatsuki K. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res 1995; 78: 117-125.

22.

Stephens K.E. , Ishizaka A. , Lamck J.W. , Raffin T.A. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis 1988; 137: 1364-1370.

23.

Gibbs L.S. , Lai L. , Malik A.B. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J Cell Physiol 1990; 145: 496-500.

24.

Lundblad R. , Ekstrom P. , Giercksky K.E. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Shock 1995; 3: 210-215.

25.

Remick D. , Manohar P. , Bolgos G. , Rodriguez J. , Moldawer L. , Wollenberg G. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 1995; 4: 89-95.

26.

Mantovani A. , Bussolino F. , Dejana E. Cytokine regulation of endothelial cell function . FASEB J 1992; 6: 2591-2599.

27.

Badolato R. , Johnston J.A. , Wang J.M. , et al. Serum amyloid A induces calcium mobilization and chemotaxis of human myocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 1995; 155: 4004-4010.

28.

Gadina M. , Bertini R. , Mengozzi M. , Zandalasini M. , Mantovani A. , Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Fxp Med 1991; 173: 1305-1310.

29.

Sironi M. , Gadina M. , Kankova M. , et al. Differential sensitivity of in vivo TNF and IL-6 production to modulation by antiinflammatory drugs in mice. Int J Immunopharmacol 1992; 14: 1045-1050.

30.

Sipe J.D. , Gonnerman W.A. , Loose L.D. , Knapschaefer G. , Xie W.J. , Franzblau C. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J Immunol Methods 1989; 125: 125-135.

31.

Tracey W.R. , Tse J. , Carter G. Lipopoiysacchande-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 1995; 272: 1011-1015.